REQUIP

USDailyMed:Ropinirole N04BC04(WHO)QV03AB96(WHO) BR:Class C1(Other controlled substances)US:℞-onlyIn general: ℞ (Prescription only) 4-[2-(Dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one 91374-21-9Y 5095 7295 DB00268Y 4916Y 030PYR8953 D08489Y CHEBI:8888Y ChEMBL589Y DTXSID8045195 Interactive image O=C2Nc1cccc(c1C2)CCN(CCC)CCC InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13‍‍‍‍‍‍​​​‍​​​​​​)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)YKey:UHSKFQJFRQCDBE-UHFFFAOYSA-NY Ropinirole, sold under the brand nameRequipamong others, is amedicationused to treatParkinson's disease(PD) andrestless legs syndrome(RLS).It is takenby mouth. Common side effects include sleepiness, vomiting, and dizziness.Serious side effects may includepathological gambling,hypersexuality,low blood pressure with standingandhallucinations.Use inpregnancyandbreastfeedingis of unclear safety.It is adopamine agonistand works by triggeringdopamine D2receptors. It was approved for medical use in the United States in 1997.It is available as ageneric medication.In 2023, it was the 212th most commonly prescribed medication in the United States, with more than 2million prescriptions.